Parafluorofuranylfentanyl
Chemical compound
- US: Schedule I[1]
- N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide
- 1802489-71-9
- 91825762
- 44211060
- FD4PG6KRQ8
- DTXSID301018394
- Interactive image
- C1CN(CCC1N(C2=CC=C(C=C2)F)C(=O)C3=CC=CO3)CCC4=CC=CC=C4
InChI
- InChI=1S/C24H25FN2O2/c25-20-8-10-21(11-9-20)27(24(28)23-7-4-18-29-23)22-13-16-26(17-14-22)15-12-19-5-2-1-3-6-19/h1-11,18,22H,12-17H2
- Key:MGEQOAJOFFXWTR-UHFFFAOYSA-N
para-Fluorofuranylfentanyl (FFF, p-F-Fu-F) is an opioid analgesic that is an analog of fentanyl and has been sold as a designer drug.[2] As with other fentanyl analogues, parafluorofuranylfentanyl has significant side effects including itching, nausea and potentially serious respiratory depression, which can be life-threatening, and it has been linked to numerous deaths from overdose.[3] It falls within the definition of Schedule I drugs in the USA under federal drug analogue legislation, and is specifically listed as a Schedule I drug in North Dakota.[4]
See also
- Furanylfentanyl
- Parafluorofentanyl
- List of fentanyl analogues
References
- ^ Drug Enforcement Administration, Department of Justice (2018). "Schedules of Controlled Substances:Temporary Placement of Fentanyl-Related Substances in Schedule I. Temporary amendment; temporary scheduling order". Federal Register. 83 (25): 5188–92. PMID 29932611.
- ^ Vincenti F, Montesano C, Di Ottavio F, Gregori A, Compagnone D, Sergi M, Dorrestein P (2020). "Molecular Networking: A Useful Tool for the Identification of New Psychoactive Substances in Seizures by LC-HRMS". Frontiers in Chemistry. 8: 572952. doi:10.3389/fchem.2020.572952. PMC 7723841. PMID 33324608.
- ^ Rodriguez Salas J, Krotulski AJ, Newman R, Thogmartin JR, Mohr AL, Logan BK (April 2022). "Concentrations of para-Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations". Journal of Analytical Toxicology. 46 (4): 358–373. doi:10.1093/jat/bkab025. PMID 33693685.
- ^ "AN ACT to amend and reenact sections 19-03.1-05, 19-03.1-11, and 19-03.1-13 of the North Dakota Century Code, relating to the scheduling of controlled substances; and to declare an emergency" (PDF). Sixty-eighth Legislative Assembly of North Dakota in Regular Session. 3 January 2023.
- v
- t
- e
(MOR)
(DOR)
(KOR)
(NOP)
Agonists |
|
---|---|
Antagonists |
|
- Enkephalinase inhibitors: Amastatin
- BL-2401
- Candoxatril
- D -Phenylalanine
- Dexecadotril (retorphan)
- Ecadotril (sinorphan)
- Kelatorphan
- Racecadotril (acetorphan)
- RB-101
- RB-120
- RB-3007
- Opiorphan
- Selank
- Semax
- Spinorphin
- Thiorphan
- Tynorphin
- Ubenimex (bestatin)
- Propeptides: β-Lipotropin (proendorphin)
- Prodynorphin
- Proenkephalin
- Pronociceptin
- Proopiomelanocortin (POMC)
- Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)